Skip to content

Clinical trials

Breast Neoplasms trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: Saudi Arabia Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20051
20061
20081
20093
20101
20111
20123
20131
20143
20164
20175
20181
20193
20201
20214
20221
20233
20241
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Active, not recruiting7
Recruiting5
Unknown status5
Suspended2
Not yet recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche8
AstraZeneca7
King Faisal Specialist Hospital & Research Center4
National Guard Health Affairs4
Novartis Pharmaceuticals4
Eli Lilly and Company2
Pfizer2
SWOG Cancer Research Network2
Al-Azhar University1
Assiut University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms46
Neoplasm Metastasis4
Triple Negative Breast Neoplasms3
Brain Neoplasms1
Breast Diseases1
Breast Neoplasms, Male1
Carcinoma, Non-Small-Cell Lung1
Cardiotoxicity1
Lung Neoplasms1
Lymphatic Metastasis1

Trials

Showing 51 to 46 of 46. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.